Clinical Roundup Combination therapy found effective for multiple myeloma patients September 06, 2019Vol.45 No.33
Clinical Roundup GSK announces positive results from the DREAMM-2 study for multiple myeloma September 06, 2019Vol.45 No.33
Drugs & Targets Syapse, FDA form research collaboration on the regulatory use of real-world evidence September 06, 2019Vol.45 No.33
Drugs & Targets Calquence granted Breakthrough Therapy designation for CLL September 06, 2019Vol.45 No.33
Drugs & Targets European Commission approves Empliciti + pomalidomide and dexamethasone for multiple myeloma September 06, 2019Vol.45 No.33
Drugs & Targets European Commission approves Imbruvica for expanded use in two indications September 06, 2019Vol.45 No.33
Drugs & Targets FDA Grants XTANDI application Priority Review for metastatic hormone-sensitive prostate cancer September 06, 2019Vol.45 No.33
Drugs & Targets DARZALEX approved for frontline multiple myeloma in Japan September 06, 2019Vol.45 No.33
